Escalating Health Issues and API The Active Pharmaceutical Ingredients (API) market is increasing constantly, as it is a crucial active raw material used in medicines to determine their strength, dosage

India and China are dominating the API industry globally, driven by several factors, including low labour costs, a highly skilled workforce, strong infrastructure, numerous USFDA/EMA-approved plants, and government-friendly policies. For

Desvenlafaxine succinate market strengthens as FDA approvals support broader antidepressant therapy adoption. Industry Overview Desvenlafaxine succinate market is growing at a CAGR of 2.8% during the forecast period (2025-2035). Desvenlafaxine

Dr. Reddy’s Laboratories has officially received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (US FDA) for the Active Pharmaceutical Ingredient (API) manufacturing facility in Middleburgh,

Increasing infectious disease prevalence, growth of generic formulations, and growing healthcare availability are fueling the Amoxicillin Sodium market. Industry Overview Amoxicillin sodium market is growing at a CAGR of 1.9%

Zydus Lifesciences has reached a significant regulatory milestone as the US Food and Drug Administration (FDA) has given a No Action Indicated (NAI) status to its Active Pharmaceutical Ingredient (API)

Tamsulosin Hydrochloride Market finds new growth paths through off-label prescribing for female urinary retention and chronic pelvic pain. Industry Overview Tamsulosin hydrochloride market is growing at a CAGR of 6.3%